Differential long-term effects of insulin-like growth factor-I (IGF-I) growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats

Endocrinology
P J FielderR G Clark

Abstract

The long-term effects of recombinant human insulin-like growth factor-I (rhIGF-I) and GH (rhGH) on body growth and the IGF-I/IGF binding protein (IGFBP)/acid-labile subunit (ALS) axis were investigated in hypophysectomized (hypox) rats given excipient, rhIGF-I (2 mg/kg.day s.c., minipumps), rhGH (2 mg/kg.day, s.c., daily injections), or rhIGF-I plus rhGH for 28 days. The relative growth-promoting activity of the treatments was rhGH plus rhIGF-I more than rhGH more than rhIGF-I. Weight gain induced by rhIGF-I progressively declined after 4 days, compared with a more maintained effect of rhGH. At day 28, growth responses did not correlate with serum IGF-I levels [rhGH plus rhIGF-I (492 +/- 140) > rhIGF-I (322 +/- 75) > rhGH (85 +/- 26) > control (39 +/- 7 ng/ml)]. Serum ALS concentrations in hypox rats were remarkably low (0.42 +/- 0.04 micrograms/ml) but were restored toward normal by rhGH (12.55 +/- 4.78) or rhGH plus rhIGF-I (12.85 +/- 6.64) but not by rhIGF-I alone (0.85 +/- 0.25). Antibodies against rhGH were present at day 28, with titer being negatively related to weight gain, IGF-I, and ALS levels. All treatments increased serum IGFBP-3. The molecular size distribution of IGFBP-3 in rhGH-treated rats was similar to that o...Continue Reading

Citations

May 10, 2006·Journal of Endocrinological Investigation·A BarrecaR Lorini
Nov 6, 2004·Breast Cancer Research and Treatment·Gudmundur ThordarsonFrank Talamantes
Jan 24, 2009·European Journal of Nutrition·Armida Báez-SaldañaRafael Saavedra
Nov 28, 2007·Endocrine·Weiguo YaoWei-Hua Lee
Feb 10, 2009·Advances in Therapy·Arlan L Rosenbloom
Mar 30, 2007·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Mogher KhamaisiAllan Flyvbjerg
Feb 13, 2001·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·P B JohansenK Malmlöf
Sep 27, 2015·Molecular and Cellular Endocrinology·Richard C Lindsey, Subburaman Mohan
Jan 12, 2010·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Denis Pioli dos SantosMaeli Dal Pai-Silva
May 6, 1998·European Journal of Clinical Investigation·C Ohlsson, O Vidal
Jul 17, 2007·Current Opinion in Pediatrics·Arlan L Rosenbloom
Mar 12, 1998·Endocrine Reviews·C OhlssonM C Slootweg
Apr 18, 2001·Journal of Pediatric Endocrinology & Metabolism : JPEM·M E Wilson
Aug 26, 1998·The Journal of Clinical Endocrinology and Metabolism·P F Collett-SolbergP Cohen
Feb 13, 2001·Endocrine Reviews·D Le RoithA Butler
May 29, 2000·American Journal of Physiology. Endocrinology and Metabolism·C H LangR A Frost
Aug 19, 2007·The Journal of Biological Chemistry·Douglas J DiGirolamoThomas L Clemens
Apr 7, 2020·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·George M Bright, Juan Francisco Fierro-Renoy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.